| 000 | 01363 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250517103010.0 | ||
| 264 | 0 | _c20170419 | |
| 008 | 201704s 0 0 eng d | ||
| 022 | _a1931-8448 | ||
| 024 | 7 |
_a10.1089/mdr.2016.0053 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJagielska, Elzbieta | |
| 245 | 0 | 0 |
_aLytM Fusion with SH3b-Like Domain Expands Its Activity to Physiological Conditions. _h[electronic resource] |
| 260 |
_bMicrobial drug resistance (Larchmont, N.Y.) _cSep 2016 |
||
| 300 |
_a461-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xbiosynthesis |
| 650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
| 650 | 0 | 4 |
_aCell Wall _xchemistry |
| 650 | 0 | 4 |
_aEndopeptidases _xgenetics |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 |
_aLysostaphin _xmetabolism |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aProtein Domains |
| 650 | 0 | 4 | _aProtein Engineering |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xbiosynthesis |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aChojnacka, Olga | |
| 700 | 1 | _aSabała, Izabela | |
| 773 | 0 |
_tMicrobial drug resistance (Larchmont, N.Y.) _gvol. 22 _gno. 6 _gp. 461-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/mdr.2016.0053 _zAvailable from publisher's website |
| 999 |
_c26168122 _d26168122 |
||